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Purpose: At Stanford Health Care, as part of a hospital-wide initiative to reduce
pneumonia readmission rates, an interdisciplinary collaborative effort was
created between physicians and transitions of care (ToC) pharmacists to optimize discharge planning and medication management for pneumonia patients.
The purpose of this study was to describe the impact of the ToC pharmacist in
identifying and reducing medication errors on discharge for pneumonia patients.
Methodology: Retrospective chart review was conducted on patients discharged
with a pneumonia diagnosis between December 2015 to Feb 2016. Patients were
stratified based on whether they received ToC pharmacist medication review
vs. standard of care. Errors were identified by comparing the patient discharge
medication list to the physician discharge summary, home, and inpatient medication lists. Errors rates were compared and stratified by error type. Pharmacist
interventions were quantified.
Results: Of the 125 patients discharged with pneumonia, 69 patients received
ToC pharmacist medication review, while 56 patients received standard of care.
In the ToC intervention group, 6 errors were identified for 5 patients, which
equates to an error rate of 7.2%. In the standard of care group, 85 medication
errors were identified for 36 patients (64.3% error rate). The difference was statistically significant (P < 0.0001) and corresponds to an 88.8% relative decrease.
The most common error recorded was incorrect medication/dose/frequency.
During this time, the ToC pharmacist had 71 documented interventions.
Conclusions: ToC pharmacist interventions demonstrated a clinically and statistically significant decrease in medication discrepancies, as well as an increased
rate of accuracy of the discharge medication list. Continued metrics and interventions are being collected to assess the impact of the ToC pharmacists on
patient outcomes.
Keywords: Transitions of care, discharge medication reconciliation, discharge
medication education, pneumonia, med errors, formulary

Introduction
Patients admitted to the hospital with a diagnosis of pneumonia are at high risk for
readmission. In 2012, the Affordable Care Act established the Hospital Readmission
Reduction Program, which requires the Centers for Medicare and Medicaid Services
(CMS) to reduce payments to hospitals with excess readmissions. Applicable conditions, including heart failure, myocardial infarction, and pneumonia, are penalized for
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unplanned readmissions within 30 days
of hospital discharge.1 As a result, many
hospitals are expanding transitions of
care (ToC) services to optimize discharge
planning and medication management.
Unintended medication discrepancies
during ToC have contributed to
adverse drug events and may play
a role in hospital readmissions.2 A
medication reconciliation pilot at John
Hopkins Hospital found that 40% of
patients had at least one unintended
discrepancy on hospital admission
or discharge. Twenty-nine percent of
those discrepancies had the potential
to result in moderate or severe adverse
drug events.3 To address medication
safety, The Joint Commission has
implemented National Patient Safety
Goal 03.06.01 to guide hospitals in
maintaining and communicating
accurate patient medication
information.4 The Joint Commission
defines medication reconciliation as
comparing medications the patient
is or should be taking to newly
prescribed medications, and resolving
discrepancies. Specific elements
of performance are provided to
perform complete and comprehensive
medication reconciliation.
At our institution, a service line of ToC
pharmacists was introduced in 2012 to
reduce readmissions and medication
errors in our high risk cardiac and general
medicine patient populations. The role
of this pharmacist includes reviewing
prior to admission medication histories,
performing medication reconciliation,
identifying and addressing barriers
to discharge, reviewing discharge
medications, and providing discharge
medication education to the patient
and/or family/caregivers. Pharmacist
interventions are prioritized for highrisk patient populations, including
patients with high-risk medications,
polypharmacy, and high-risk disease
states, including pneumonia.

As part of a hospital-wide initiative to
reduce pneumonia readmission rates
at our institution, an interdisciplinary
collaborative effort was created between
physicians and ToC pharmacists to optimize medication regimens for pneumonia
patients on hospital discharge. While
there is data available on the impact of
ToC pharmacists in reducing medication errors and readmission rates in the
general population, there is very limited
data focusing on outcomes in pneumonia patients. Given the high risk for
readmission in this patient population,
the reimbursement penalty for excess
readmissions, and the changes to patient
medications on hospital admission and
discharge, it is prudent and important
to evaluate the incidence of medication
errors and the outcomes associated with
implementing ToC interventions.5 The
purpose of this study was to describe the
impact of ToC pharmacists in identifying and reducing medication errors on
discharge for pneumonia patients.

Methodology
Intervention
Pharmacists participated in a daily sign
off with the general medicine teams to
identify all admitted pneumonia patients
and begin preparing their medication
list in anticipation of discharge. Patients
admitted with a diagnosis of pneumonia
may have many changes to their home
medication regimens, not limited to:
prescription of new antibiotics, renal dose
adjustments to existing medications, and
changes to anticoagulation, blood pressure or diabetic regimens, which may be
held or adjusted during their hospital stay.
Upon discharge, medication lists were
evaluated for accuracy and completeness.
In addition to evaluating the accuracy
of medication lists, ToC pharmacists
and physicians collaborated to ensure
patients had appropriate follow-up visits,
and to address any access or formulary
issues which may prevent the patient
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from picking up their medication post
discharge. This included completing
prior authorizations, checking for stock
of medication, and arranging medication
delivery to bedside before discharge when
appropriate. Patients were educated by the
ToC pharmacist on their medications and
follow up instructions before discharge.

Study Design
To evaluate the impact of this
intervention, a retrospective chart
review was conducted on all patients
discharged with a diagnosis of
pneumonia between December 2015
to February 2016. Our institution uses
the Epic (Verona, Wisconsin) electronic
medical record system, which allows for
tracking of pharmacist interventions,

Table 1. Baseline Characteristics
Baseline Characteristics
Age

Pharmacist Intervention
(N = 69)

No Pharmacist Intervention
(N = 56)
69 (SD: 21)

0.479

42%

39.28%

0.728

4 days

4 days

0.726

Home

56

34

0.01208

Skilled nursing facility

13

18

0.0687

Hospice

0

2

0.093

Long term care facility

0

1

0.238

Acute rehab

0

1

0.238

82.6%

53.57%

20

5

0.0054

Male
Duration of stay

72 (SD: 18)

P Value

Discharge disposition

Antibiotics on discharge

0.00044

Type of Pneumonia
Community acquired pneumonia
Healthcare-associated pneumonia

4

4

0.787

11

7

0.6455

4

1

0.285

25

26

0.267

Possible pneumonia

3

8

0.0549

Necrotizing pneumonia

1

0

0.375

Fungal pneumonia

1

0

0.375

Ventilator-associated pneumonia

0

2

0.093

Other

0

3

0.0601

Aspirational pneumonia
Viral pneumonia
Pneumonia: Unspecified
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as well as documentation of patient
medication education provided. Patients
were stratified based on whether they
had documented ToC pharmacist
medication review before discharge vs.
standard of care (medication teaching
by nursing before discharge with no
additional medication review). Baseline
characteristics were compared between
the two groups (Table 1).
Medication errors were identified
by comparing the patient discharge
medication list to the physician discharge
summary, before admission and inpatient
medication lists. For patients discharging
to home with or without home health,
the after visit summary (AVS) medication
list, which is provided to the patient on
discharge, was assessed for medication
errors. For patients discharged to a
skilled nursing facility (SNF) or another
healthcare facility, an interagency form
was assessed for medication errors. This
form, which includes a complete and
updated list of discharge medications, is
generated by Epic and provided to the
receiving facility at the time of patient
transfer. Patient-specific treatment plans,
labs, vitals and diagnostic exams were
also taken into consideration in assessing
the appropriateness of therapy.

Outcomes and
Statistical Analysis
The primary objective of this study was
to describe the incidence of medication
errors in pneumonia patients and to
evaluate the impact of the ToC pharmacist in reducing medication errors.
The secondary objective was to describe
the pharmacist interventions made for
patients who received ToC pharmacist
interventions. Errors rates were compared
between the standard of care group and
the pharmacist intervention group, and
statistical analysis was performed using
the chi-square test. Errors were stratified by error type and separated into the
following categories: prescription of
incorrect medications (wrong drug,
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strength, dosage, or frequency), missing
or incomplete instructions, duplicate
medications or therapeutic class, and
missing or omitted medications. Additionally, for patients who did receive
pharmacist medication review at the time
of hospital discharge, the interventions
made by ToC pharmacists were quantified and documented. The severity of
errors was classified as mild, moderate or
severe based on the American Society for
Healthcare Risk Management (ASHRM)
criteria.6 Errors were assessed individually by two ToC pharmacists who were in
agreement for all identified errors.

drug interaction that would affect the
appropriateness of therapy. Twenty-one
percent of errors were missing instruction errors which included missing
dose, frequency, or route, and 16% of
errors were omission errors in which
a medication was unintentionally not
prescribed. The remaining 16% of errors
were duplicate medication or duplicate
therapeutic class errors (Table 2). Errors
were classified as mild (45%) in severity,
moderate (46%), and severe (9%). While
67% of errors were identified in patients
discharged to home, 33% of errors were
identified in patients discharged to a SNF.

This study received Institutional Review
Board Approval #37647. The statistical analysis for categorical data was
performed using chi-square statistical
test, while numerical data was analyzed
using t-test with an alpha of 0.05.

In the ToC intervention group, six
medication errors were identified for
69 patients. On average, there were 0.09
errors per patient. Four errors (67%)

Results
A total of 125 patients were discharged
with pneumonia during the study
period. Sixty-nine patients' medication
lists were reviewed by ToC pharmacists,
while 56 patients received standard of
care. In the ToC intervention group,
five patients had discrepancies on their
medication list during chart review,
which equates to an error rate of 7.2%.
In the standard of care group, 36 patients
had medication errors, which equates
to an error rate of 64.3%. The difference
was statistically significant (P < 0.00001)
and corresponds to an 88.8% relative
decrease in medication errors (Table 2).
In the total patient population, 95 errors
were identified. Amongst patients who
received standard of care, or nursing
medication education at bedside, 89
medication errors were identified for
56 patients. On average, there were 1.6
errors per patient, and 47% of errors in
this group resulted from prescription of
incorrect medications. This was identified as having an incorrect medication
prescribed, having an incorrect dose or
frequency defined, or having a significant

Table 2. Classification of Errors
Classification of Errors

Pharmacist Intervention
Group (N = 69)

Standard of Care Group
(N = 56)

Number of patients with error

5 (7.2%)

36 (64.3%)

Total number of errors

6

89

Error Type
Incorrect medication

4

42

Missing Instructions

0

19

Omission

2

14

Duplicate medication

0

14

Mild

4

40

Moderate

2

41

Severe

0

8

Patients discharging home with errors

1

24

Patients discharging to SNF with errors

4

12

57

30

1

5

Error Severity

Error by Discharge Disposition

Antibiotic Prescribing
Number of patients prescribed antibiotics
Number of patients with antibiotic-related error
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were incorrect medication errors, and
two errors (33%) were omission errors
(Table 2). Errors were classified as mild
(67%) and moderate (33%) in severity.
Twenty percent of errors were identified
in patients discharged to home while
80% of errors were identified in patients
discharged to a SNF.
During this time period, the ToC
pharmacist also documented 71
interventions, which were made before
the patient’s discharge. Thirty-one
interventions were documented which
involved resolving access or formulary
issues, including resolving insurance
issues. Twenty-three interventions
addressed incorrect medication, dose or
frequency issues. Twelve interventions
addressed omitted medications, and
five interventions addressed duplicate
medications or therapeutic classes.

Discussion
We are the first to our knowledge to show
that patients admitted with a pneumonia
diagnosis would benefit from ToC interventions, including discharge medication
reconciliation. With the focus on patient
safety, many organizations, including
The Joint Commission, place significant
emphasis on medication reconciliation
around ToC. This study provides statistically significant data in advancing and
showing the importance of pharmacist
involvement in comprehensive patient
care, especially in the reduction in medication errors. Many studies may show a
need for medication reconciliation, but
there is limited literature on the pharmacist affecting outcomes of pneumonia
patients. The results show clear evidence
that during the complex situation of a
patient’s discharge or transfer of care,
medication errors do occur (33% in
this study). ToC pharmacists show a
significant benefit in ensuring the correct
medication are ordered/prescribed for
patient safety.

Overall, the baseline characteristics
were balanced between the two groups,
including age, gender, and length of stay.
The ToC group had a larger percentage
of patients discharged on an antibiotic, as
compared to the standard of care group
(82.6% vs. 53.6%, p < 0.001). This may be
attributed to the high-risk criteria used by
our ToC program to triage patients, which
includes prioritizing patients discharging
on an antibiotic. Patients who already
completed their course of antibiotics
during their admission were lower priority
for being seen by the ToC pharmacist.
However, the majority of errors identified
were unrelated to antibiotic prescribing
minimizing potential for apparent bias
(Table 2). Additionally, the ToC group
also had a larger population discharged to
home, as opposed to SNF or other assisted
care facilities (81.2% vs. 60.7%, p = 0.01).
This is also by design as the ToC program
prioritizes patients discharging home
over those discharging to a facility, due to
a greater perceived benefit based on the
assumption that patients discharging to an
acute care facility will have medications
managed by healthcare personnel.
However, since the patients discharging
to SNF did have a high rate of error, this
would not create any favorable benefit
in reporting error rates. This distinction
is also unique as most of the previous
literature for ToC programs focused on
patients discharging to the home setting.
This study sheds light on the complexity of
other dispositions as well.
While patients seen by the ToC pharmacist at discharge had significantly fewer
errors compared to the standard of care
group, the majority of errors identified in the ToC group were in patients
discharging to a SNF. The significance of
a higher error rate in patients discharged
to a SNF speaks to the overall discharge
process in this patient population. At
the time of discharge, the patient’s nurse
generates and prints an “interagency
form” which should be provided to the
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nursing facility and is accepted as the
primary source of updated medications.
However, if this list is printed too early,
and additional changes are made to the
patient's medication list by the team,
the nursing facility may be provided
with an outdated medication list. This is
further complicated by placement issues
that may arise and lead to unexpected
delays to patient discharge. In many
cases, the patient may stay hours to days
longer than originally anticipated. Upon
discharge, a new medication list should
be, but is not always, generated. For the
SNF patients seen by the ToC pharmacist,
all errors identified in chart review were
due to medication changes made to the
list after pharmacist review. There is room
for improvement in interdisciplinary
communication as well as the overall
discharge process when patients are transitioning to a SNF.
The majority of medication errors
were identified in patients who were
not seen by the ToC pharmacist at the
time of discharge. A common cause of
discharge errors was related to incorrect
medication reconciliation on admission.
This highlights the importance of
comprehensive and complete medication
reconciliation on admission, as it relates
to reducing discharge medication errors.
For example, if an incorrect dose or
frequency was entered on admission, it
is generally then incorrectly resumed on
discharge as well. A frequent source of
duplicate medication errors was due to
therapeutic interchange on admission due
to formulary restrictions. For example,
a patient may have their ACE inhibitor
changed to an alternative within the
same class once admitted, and then
both medications would be incorrectly
resumed on discharge. Another source
of error was an appropriate de-escalation
of antibiotics on discharge. The ToC
pharmacist evaluates cultures, renal
function, and days’ supply in ensuring
appropriateness of therapy. For patients
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de-escalated from IV to oral antibiotics
on discharge, errors were identified in
patients who did not receive a sufficient
supply or who did not have renallyadjusted regimens. Another source
of errors was related to unintentional
omission of medications. Many of
the patients had their blood pressure
regimens held on admission due to
hypotension secondary to sepsis. On
discharge, the medications were not
resumed despite resolution of the
hypotension. Lastly, insulin regimens
were also frequently altered in the
hospital and incorrectly resumed on
discharge not taking into account other
changes like a new steroid regimen.
Many of these errors were specific to
health status changes associated with a
pneumonia admission and highlight the
importance of comprehensively assessing
patient medication during ToC following
a pneumonia admission.
In classifying errors based on severity,
there were no severe errors in the ToC
intervention group. The standard of care
group had primarily mild and moderate
errors although there were severe errors
identified as well. Mild errors had
minimal potential for harm, such as the
omission of an over-the-counter medication. Moderate errors had the potential
for adverse effects but would not severely
affect quality of life, such as incorrect
dosing of a blood pressure medication or
an inhaled corticosteroid. Severe errors
had potential for severe harm, such as
incorrectly dosing anticoagulants, which
was seen in several patients.
In the ToC intervention group, we
evaluated interventions the pharmacist
provided at the time of patient discharge.
44% of our interventions were resolving
access or formulary issues. Clinical pharmacists at our institution participate in
daily team care rounds with physicians,
nurses and case managers, to anticipate
and address barriers to discharge. We
assisted with identifying medications
that would have a high copayment or

require prior authorization, as well as
ensuring or securing stock of medication, and coordinating delivery to
bedside when appropriate. A significant
portion of our interventions revolved
around ensuring our patients were able
to access their medications on discharge,
so as not to delay discharge or increase
the risk of readmission.
While the primary outcome of this study
evaluated the impact of ToC pharmacists
in reducing medication errors, there was
tremendous value in collaborating with
physicians to anticipate and plan for
discharge. Typically, the ToC pharmacist
is notified when discharge orders are
placed for a patient and has limited time
to review the medication list, educate
the patient, and resolve any medicationrelated issues. Daily sign off allowed
the pharmacist to anticipate discharges
in advance, which provided time to
coordinate teaching with the patient
and caregivers or family members,
review the medication list for medications which might be problematic for
insurance claims, as well as collaborate
with the physicians to set up any follow
up appointments for acute or chronic
disease states identified during their
hospital admission.

The ToC pharmacist
interventions
reduced medication
discrepancies and
increased the rate of
accuracy for patients
admitted with a
diagnosis of pneumonia.

The ToC pharmacist interventions
reduced medication discrepancies and
increased the rate of accuracy for patients
admitted with a diagnosis of pneumonia.
Future studies would benefit from further
evaluating the impact of interdisciplinary
efforts in optimizing ToC. While our
results did not focus on cost savings or
readmission rates, we hope that future
research is able to address how ToC pharmacist interventions can be translated
into favorable outcomes in readmission
reduction and health care cost savings
related to medication error, discharge
delays, and excessive readmissions.
At our institution, we expanded our
ToC pharmacist services to include a
dedicated pharmacist for our high-risk
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medicine patients, including pneumonia
patients. We continue to collaborate with
our medicine teams to plan for discharge
and participate in daily interdisciplinary
rounds to anticipate and address patientspecific needs during ToC.

Limitations
Limitations of our study were that it
was conducted as a retrospective chart
review in a single academic medical
center. While randomized controlled
trials are the gold standard, it would
not have been ethical to intentionally
withhold care to a subset of our patient
population who would benefit from
pharmacist medication review, based
on our ToC program criteria. However,
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the two groups were overall similar in
baseline characteristics. At the time of
this study, our service was comprised of
two pharmacists, and our workflow was
limited by staffing and rolling discharges.
Therefore, despite our best attempt to
see all patients who meet our program
criteria, patients could still discharge
without pharmacist medication review
or education. Additionally, our study was
conducted over a shorter period with
a relatively small patient population.
However, statistically significant results
were demonstrated. Future steps
should expand upon this research to
evaluate the impact of ToC pharmacist
interventions and medication error
reduction on readmission rates and
hospital-related costs.
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Conclusion
To our knowledge, this is the first study
to show the importance of pharmacist
involvement in reducing medication
errors in pneumonia patients on hospital
discharge. The ToC pharmacist interventions demonstrated a clinically
and statistically significant decrease
in medication discrepancies, as well
as an increased rate of accuracy of the
discharge medication list. The ToC
pharmacists most documented interventions included identifying and resolving
access or formulary issues and incorrect
frequency, dose, or duration of therapy.
Continued metrics and interventions are
being collected to assess the impact of the
ToC pharmacist on patient outcomes. o

